BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17118742)

  • 1. Quality of nuchal translucency measurements in multifetal pregnancies.
    Zohav E; Segal O; Rabinson J; Meltcer S; Anteby EY; Orvieto R
    J Matern Fetal Neonatal Med; 2006 Oct; 19(10):663-6. PubMed ID: 17118742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of maternal and fetal parameters on the quality of nuchal translucency measurement.
    Zohav E; Dunsky A; Segal O; Peled R; Herman A; Segal S
    Ultrasound Obstet Gynecol; 2001 Dec; 18(6):638-40. PubMed ID: 11844205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control of an image-scoring method for nuchal translucency ultrasonography.
    Fries N; Althuser M; Fontanges M; Talmant C; Jouk PS; Tindel M; Duyme M
    Am J Obstet Gynecol; 2007 Mar; 196(3):272.e1-5. PubMed ID: 17346552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuchal translucency thickness in euploid fetuses: is two millimeters too risky?
    Fink M; Sheiner E; Sheizaf B; Hershkovitz R; Bashiri A; Mazor M; Wiznitzer A
    Am J Perinatol; 2009 Apr; 26(4):303-7. PubMed ID: 19031359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
    Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
    Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Education and quality review for nuchal translucency ultrasound.
    D'Alton ME; Cleary-Goldman J
    Semin Perinatol; 2005 Dec; 29(6):380-5. PubMed ID: 16533651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A significant linear association exists between nuchal translucency thickness and adverse perinatal outcome in euploid fetuses.
    Sheizaf B; Sheiner E; Fink M; Hershkovitz R; Mazor M; Wiznitzer A
    J Matern Fetal Neonatal Med; 2009 Jun; 22(6):479-84. PubMed ID: 19479642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-trimester ultrasonographic screening for trisomy 21 using fetal nuchal translucency and nasal bone.
    Sepulveda W; Wong AE; Dezerega V
    Obstet Gynecol; 2007 May; 109(5):1040-5. PubMed ID: 17470580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal gender and sonographic assessment of crown-rump length: implications for multifetal pregnancy reduction.
    Becker S; Ural S; Fehm T; Bienstock J
    Ultrasound Obstet Gynecol; 2004 Sep; 24(4):399-401. PubMed ID: 15343593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interfetal heart rate and size variation in first-trimester multifetal pregnancies and heart rate of surviving fetuses after fetal reduction.
    Zimmer EZ; Chao CR; Sharma S; Timor-Tritsch IE
    Ultrasound Obstet Gynecol; 1997 Apr; 9(4):253-6. PubMed ID: 9168576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuchal translucency in dichorionic twins conceived after assisted reproduction.
    Hui PW; Tang MH; Ng EH; Yeung WS; Ho PC
    Prenat Diagn; 2006 Jun; 26(6):510-3. PubMed ID: 16639691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuchal translucency in pregnancies conceived after assisted reproduction technology.
    Hui PW; Lee CP; Tang MH; Ho PC
    Curr Opin Obstet Gynecol; 2006 Jun; 18(3):319-24. PubMed ID: 16735833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What information on fetal anatomy can be provided by a single first-trimester transabdominal three-dimensional sweep?
    Fauchon DE; Benzie RJ; Wye DA; Cairns DR
    Ultrasound Obstet Gynecol; 2008 Mar; 31(3):266-70. PubMed ID: 18307174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for adverse pregnancy outcome by ductus venosus Doppler at 11-13+6 weeks of gestation.
    Maiz N; Valencia C; Emmanuel EE; Staboulidou I; Nicolaides KH
    Obstet Gynecol; 2008 Sep; 112(3):598-605. PubMed ID: 18757658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midtrimester maternal serum inhibin A levels after multifetal pregnancy reduction.
    Chen HJ; Huang LW; Lin YH; Seow KM; Hsieh BC; Hwang JL; Tzeng CR
    Prenat Diagn; 2007 May; 27(5):431-4. PubMed ID: 17295349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial.
    D'Alton ME; Cleary-Goldman J; Lambert-Messerlian G; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor IE; Carr SR; Wolfe HM; Dukes K; Canick JA; Malone FD
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):142-6. PubMed ID: 19173241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of fetal position on nuchal translucency thickness.
    de Graaf IM; Müller MA; van Zuylen-Vié AA; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 2000 Jun; 15(6):520-2. PubMed ID: 11005121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Valencia C; Maiz N; Nicolaides KH
    Hum Reprod; 2008 Sep; 23(9):1968-75. PubMed ID: 18544579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quality of nuchal transluccency measurements: an exploratory study into their performance and evaluation].
    van den Berg M; Kleinveld JH; Sander MJ; van Vugt JM; Timmermans DR
    Ned Tijdschr Geneeskd; 2005 Jul; 149(30):1691-6. PubMed ID: 16104116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.